Active	Status	Sponsor type	Region	Phase	Filter
106 Active 43 Inactive 149 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

106 Trials

Active Trials   

«12

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kreutziger, Janett
NCT05679635: Evaluation of Tracheal Pressure During CPAP	Completed	N/A	20	Europe	Evone, Evita Infinity V500	Medical University Innsbruck	Continuous Positive Airway Pressure, CPAP Ventilation	05/24	05/24
Wagner, Julian
NCT05679635: Evaluation of Tracheal Pressure During CPAP	Completed	N/A	20	Europe	Evone, Evita Infinity V500	Medical University Innsbruck	Continuous Positive Airway Pressure, CPAP Ventilation	05/24	05/24
Abfalterer, Hannes
HARVITA, NCT05931783: Randomized Comparison of Skeletonized Versus Pedicled Left Internal Thoracic Artery	Recruiting	N/A	1350	Europe	skeletonized harvesting technique, pedicled harvesting technique	Medical University Innsbruck	Coronary Artery Disease	10/28	10/31
Sinner, Barbara
RAPID-II, NCT05990790: The Effect of Desflurane Versus Sevoflurane Versus Propofol on Postoperative Delirium	Recruiting	4	1332	Europe	Desflurane, Sevoflurane, Propofol	Medical University of Vienna, Medical University of Innsbruck	Postoperative Delirium, Major Noncardiac Surgery, Postoperative Cognitive Dysfunction	12/27	12/28
PAC-AIM, NCT06222866: Anticoagulation and Inflammation Monitoring in Patients After Heart and Vascular Interventions	Not yet recruiting	N/A	400	Europe	Anticoagulation monitoring	Medical University Innsbruck	Heart Surgery, Vascular Surgery, Delirium, Hyperinflammatory Syndrome	03/26	04/26
Riemer, Birgit
CYPRESS, NCT05696717: Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy	Recruiting	3	102	Europe, Canada, US, RoW	Ampreloxetine, TD-9855, Placebo	Theravance Biopharma	Symptomatic Neurogenic Orthostatic Hypotension, MSA - Multiple System Atrophy	12/24	01/27

 

«12